Use of the purified poloxamer 407 for temporary coronary occlusion in off-pump CABG does not cause myocardial injury

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

Volumn 2, Issue 4, 2007, Pages 201-204

  Mommerot, Arnaud ^a   Aubin, Marie Claude ^b   Carrier, Michel ^a   Cohn, William E ^c   Perrault, Louis P ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

Coronary occlusion; Evolving technologies; Minimally invasive CABG; Myocardial ischemia

Indexed keywords

CREATINE KINASE MB; POLOXAMER; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME BLOOD LEVEL; FEMALE; HEART INFARCTION; HEART MUSCLE INJURY; HEMOSTASIS; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION;

EID: 35048884638     PISSN: 15569845     EISSN: 15590879     Source Type: Journal    
DOI: 10.1097/IMI.0b013e318095a9e0     Document Type: Article

References (13)

1. El-Hamamsy I, Cartier R, Demers P, et al. Long-term results after systematic off-pump coronary artery bypass graft surgery in 1000 consecutive patients. Circulation. 2006;114(suppl I):I-486-I-491.
2. Khan NE, De Souza A, Mister R, et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med. 2004;350:21-28.
3. Carrier M, Perrault LP, Jeanmart H, et al. Randomized trial comparing off-pump to on-pump coronary artery bypass grafting in high-risk patients. Heart Surg Forum. 2003;6:E89-E92.
4. Stamou SC, Jablonski KA, Hill PC, et al. Coronary revascularization without cardiopulmonary bypass versus the conventional approach in high-risk patients. Ann Thorac Surg. 2005;79:552-557.
5. Perrault LP, Menasche P, Wassef M, et al. Endothelial effects of hemostatic devices for continuous cardioplegia or minimally invasive operations. Ann Thorac Surg. 1996;62:1158-1163.
6. Okazaki Y, Takarabe K, Murayama J, et al. Coronary endothelial damage during off-pump CABG related to coronary-clamping and gas insufflation. Eur J Cardiothorac Surg. 2001;19:834-839.
7. Boodhwani M, Cohn WE, Feng J, et al. Safety and efficacy of a novel gel for vascular occlusion in off-pump surgery. Ann Thorac Surg. 2005;80:2333-2337.
8. Bouchot O, Aubin MC, Carrier M, et al. Temporary coronary artery occlusion during off-pump coronary artery bypass grafting with the new poloxamer P407 does not cause endothelial dysfunction in epicardial coronary arteries. J Thorac Cardiovasc Surg. 2006;132:1144-1149.
9. Aubin MC, Bouchot O, Carrier M, et al. Temporary internal thoracic artery occlusion during off-pump coronary artery bypass grafting with the new poloxamer P407 does not cause endothelial dysfunction. J Thorac Cardiovasc Surg. 2006;132:685-686.
10. Perrault LP, Menasché P, Bidouard JP, et al. Snaring of the target vessel in less invasive bypass operations does not cause endothelial dysfunction. Ann Thorac Surg. 1997;63:751-755.
11. Raymond J, Metcalfe A, Salazkin I, et al. Temporary vascular occlusion with poloxamer 407. Biomaterials. 2004;25:3983-3989.
12. Crescenzi G, Cedrati V, Landoni G, et al. Cardiac biomarker release after CABG with different surgical techniques. J Cardiothorac Vasc Anesth. 2004;18:34-37.
13. Boodhwani M, Feng J, Mieno S, et al. Effects of purified poloxamer 407 gel on vascular occlusion and the coronary endothelium. Eur J Cardiothorac Surg. 2006;29:736-741.